A review of the current use of rituximab in autoimmune diseases - ScienceDirect
![PDF] Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to](https://d3i71xaburhd42.cloudfront.net/21ac37df332b1a5b0052324842b370aaf3521f20/6-Figure6-1.png "PDF] Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to")
PDF] Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to
Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma: Molecular Therapy - Oncolytics
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children | American Society of Nephrology
PLOS ONE: Rituximab Treatment in Hepatitis C Infection: An In Vitro Model to Study the Impact of B Cell Depletion on Virus Infectivity
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
How the discovery of rituximab impacted the treatment of B-cell non-Ho | JBM
PV | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA)
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome | Pharmacology
Rituximab | Immunopaedia
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Obinutuzumab for the treatment of non-Hodgkin lymphomas
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Main mechanisms of action of rituximab and ways to increase its... | Download Scientific Diagram
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
Rituximab: Mechanism of Action - ScienceDirect
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy
Rituxan
Use of rituximab in paediatric nephrology | Archives of Disease in Childhood
